Acute and delayed toxicity from co-ingestion of methylene chloride and methanol.
Carbon Monoxide
Methylene Chloride
case report
methanol
Journal
Toxicology communications
ISSN: 2473-4306
Titre abrégé: Toxicol Commun
Pays: England
ID NLM: 101725597
Informations de publication
Date de publication:
2019
2019
Historique:
entrez:
21
11
2019
pubmed:
21
11
2019
medline:
21
11
2019
Statut:
ppublish
Résumé
Methylene chloride is a volatile, chlorinated hydrocarbon and colorless solvent found in multiple industrial products including paint strippers, metal cleaners, automotive products, pesticides and aerosol containers. Occupational exposure to methylene chloride is reported in automotive technicians, painters, and other industrial workers with adverse health effects including gastrointestinal, neurological, as well as hepato-renal injuries. International Agency for Research on Cancer (IARC) classifies methylene chloride as a 2 A carcinogen. Through a series of reactions catalyzed by cytochrome P450 2E1 (CYP2E1), metabolism of methylene chloride leads to the formation of formyl chloride, and ultimately carbon monoxide (CO). Most reports of methylene chloride toxicity are due to dermal and inhalational exposure in occupational settings. Ingestion of methylene chloride is uncommon, yet can lead to significant toxicity and prolonged CO toxicity. Methylene chloride is frequently formulated with methanol; individuals who intentionally ingest methylene chloride can experience concomitant methanol toxicity. We present a case of acute ingestion of paint stripper containing methanol and methylene chloride. We discuss the clinical presentation, key management decisions, relevant pathophysiology and biochemistry, as well as the clinical course and management.
Identifiants
pubmed: 31745533
doi: 10.1080/24734306.2019.1685222
pmc: PMC6863342
mid: NIHMS1059240
doi:
Types de publication
Journal Article
Langues
eng
Pagination
79-84Subventions
Organisme : NIDA NIH HHS
ID : K23 DA044874
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA047236
Pays : United States
Références
Br J Ophthalmol. 2002 Sep;86(9):1064-5
pubmed: 12185141
N Engl J Med. 2018 Jan 18;378(3):270-280
pubmed: 29342392
Am J Med. 2011 May;124(5):e3-4
pubmed: 21531220
Workplace Health Saf. 2018 Feb;66(2):108
pubmed: 29053053
Br Med J. 1976 Jan 3;1(6000):20-1
pubmed: 1247717
Toxicol Appl Pharmacol. 1996 Dec;141(2):373-81
pubmed: 8975761
Crit Care Med. 2015 Feb;43(2):461-72
pubmed: 25493973
J Emerg Med. 1983;1(1):51-8
pubmed: 6386968
J Intern Med. 2005 Aug;258(2):181-90
pubmed: 16018795
Am J Epidemiol. 2011 Feb 15;173(4):404-13
pubmed: 21228414
J Toxicol Clin Toxicol. 2002;40(4):415-46
pubmed: 12216995
J Toxicol Clin Toxicol. 1999;37(4):497-504
pubmed: 10465248
Med Toxicol. 1986 Sep-Oct;1(5):309-34
pubmed: 3537623
Toxicol Sci. 2006 Jun;91(2):576-85
pubmed: 16569727
Expert Opin Drug Metab Toxicol. 2008 Jun;4(6):697-720
pubmed: 18611112
Am Fam Physician. 1993 Jan;47(1):163-71
pubmed: 8418579
Br J Clin Pharmacol. 2016 Mar;81(3):505-15
pubmed: 26551875
Ann Emerg Med. 1989 Jun;18(6):691-5
pubmed: 2729697
J Toxicol Clin Toxicol. 2000;38(3):297-303
pubmed: 10866330
Basic Clin Pharmacol Toxicol. 2016 Aug;119(2):228-38
pubmed: 26806851